Across TCGA pan-cancer cohorts, PPIAP88 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated PPIAP88 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher PPIAP88 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PPIAP88 expression acts as an unfavorable survival marker, although some lineages such as COAD and CESC show a favorable association.
ACC, UVM, and UCS are the cancer types where PPIAP88 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.